about
Fasciola hepatica-induced acute pancreatitis: report of two cases and review of the literature.Seroepidemiology of Fasciola Hepatica in Mersin province and surrounding towns and the role of family history of the Fascioliasis in the transmission of the parasite.Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma.Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia.Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation.A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.Long-term red blood cell exchange can be used to successfully treat sickle cell intrahepatic cholestasis: a case report.Therapeutic plasma exchange for multidrug intoxication: a case reportHelicobacter pylori-associated atrophic gastritis and carotid intima-media thickness: is there a link?Endoscopic epinephrine injection induced amaurosis fugaxInitial presentation of hepatocellular carcinoma as a subcutaneous mass on the anterior chest wallLow efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish populationEctopic opening of the common bile duct into various sites of the upper digestive tract: a case seriesUltrasonographic features of a large B-cell lymphoma of the gallbladderEctopic opening of the common bile duct into the stomach
P50
Q37792940-5CABB307-945E-4552-BC46-742582FF7656Q39903563-648D81D7-7DDF-412B-A675-5D99B58865B7Q42181602-30638189-0701-46C4-9800-E1B7D9DB8AA7Q42233721-B6C224BE-1ACE-4CC0-879C-47C429BE38FEQ45110059-6AC70AD5-6B02-4A71-A1B7-32F48A1FD1A6Q45195148-69707AA9-A0EE-4926-A7B2-0CFD4C35280FQ46900767-764C36FC-7A42-4038-9F36-8B5796C0A96EQ50799434-DBC61583-37E2-485A-B3FD-DFCB57038BD9Q79188210-C774EF5E-48C9-44F0-81CB-64144E1DC47AQ79894354-1BDFADC2-2FCB-4C2F-9D95-E18C15DFAC43Q80119708-DC407639-177F-431A-AF7F-8FCE4ABD5562Q80177061-AB3255F6-68E8-4521-9E17-88A902DBA2E7Q80967785-5245336E-A89A-4F22-8ADB-E10EB16C3037Q84281099-B277DBA6-6952-45DD-A7E9-AFD52C91FC94Q84701524-459277C3-AF16-4307-AAC2-3ADFD2C50877Q85096707-9C620AB0-0B70-49FA-874B-97159C667E68
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Engin Altintas
@ast
Engin Altintas
@en
Engin Altintas
@es
Engin Altintas
@nl
type
label
Engin Altintas
@ast
Engin Altintas
@en
Engin Altintas
@es
Engin Altintas
@nl
prefLabel
Engin Altintas
@ast
Engin Altintas
@en
Engin Altintas
@es
Engin Altintas
@nl
P106
P1153
6701552668
P31
P496
0000-0003-0796-1456